Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MEDNAX Inc    MD

MEDNAX INC (MD)
Mes dernières consult.
Most popular
Rapport
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales2 439-3 1833 4183 6393 972
EBITDA559654695571609648
Operating profit (EBIT)513632666467503547
Pre-Tax Profit (EBT)------
Net income317-325249270281
P/E ratio20,820,019,115,714,513,9
EPS ( $ )3,183,583,492,682,913,03
Dividend per Share ( $ )------
Yield------
Reference price ( $ )66.1171.6666.6642.1242.1242.12
Announcement Date01/29/2015
11:00am
-02/07/2017
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt515-1 6391 6391 6771 892
Finance------
Operating income (EBITDA)559654695571609648
Leverage
(Debt/EBITDA)
0,92x-2,36x2,87x2,75x2,92x
Capital Expenditure18,127,139,344,337,945,5
Book Value Per Share (BVPS)22,6 $25,9 $29,5 $31,8 $34,0 $34,3 $
Cash Flow per Share4,23 $3,92 $4,77 $4,08 $4,07 $4,09 $
Announcement Date01/29/2015
11:00am
02/07/2017
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 3 941 M$ -
Entreprise Value (EV) 5 580 M$ 5 618 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 15,7x 14,5x
Capitalization / Revenue 1,15x 1,08x
EV / Revenue 1,63x 1,54x
EV / EBITDA 9,77x 9,22x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,32x 1,24x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 13,7% 13,8%
operating Leverage (Delta EBIT / Delta Sales) - 1,17x
Net Margin (Net Profit / Revenue) 7,30% 7,42%
ROA (Net Profit / Asset) 5,60% 5,10%
ROE (Net Profit / Equities) 10,3% 10,0%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,30% 1,04%
Cash Flow / Sales 11,2% 10,5%
Capital Intensity (Assets / Sales) 1,30x 1,45x
Financial Leverage (Net Debt / EBITDA) 2,87x 2,75x
EPS & Dividend